Recent Finacing
Recent Raise
Human Life Code develops and manufactures umbilical-cord–derived mesenchymal stromal cell (UC-MSC) therapies aimed at treating intractable diseases and extending healthy lifespans.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at ヒューマンライフコード.
